Phuturdex › Diseases › Atrophic muscular disease
Drugs in development · updated 30 October 2026
Atrophic muscular disease: drugs in development
As of 30 October 2026 there are 4 active clinical trials (recruiting or ongoing, phases I–III) on 3 drugs for atrophic muscular disease. 3 are experimental, that is not yet approved in the United States.
Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.
Sign in free →Experimental drugs
Not yet approved by the US FDA for any indication.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| AOC 1044 | III | 1 | NCT07587242 |
| Deramiocel | III | 1 | NCT05126758 |
| VX-670 | I–II | 2 | NCT06185764 |
Sorted by most advanced phase and number of active trials.
All 3 drugs, with the details
In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.
Open in Phuturdex →Specific forms
- Duchenne muscular dystrophy 35 drugs
- Myotonic dystrophy 10 drugs
- Facioscapulohumeral muscular dystrophy 7 drugs
- Muscular Dystrophies 9 drugs
- Limb-girdle muscular dystrophy 3 drugs
- Autosomal recessive limb-girdle muscular dystrophy type 2I 3 drugs
- Neuromuscular disease 14 drugs
- Obesity 233 drugs
- Fractures, Bone 8 drugs
- Inflammation 85 drugs
- Myotonia 3 drugs
- Genetic disease 33 drugs
Broader categories
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities 4 drugs
- Neurologic Manifestations 15 drugs
- Neuromuscular manifestations 5 drugs
- Musculoskeletal disorder 22 drugs
- Neurodegenerative Diseases 25 drugs
- Nervous system heredodegenerative disease 3 drugs
Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D020966 “Muscular Disorders, Atrophic”.